We are live on
!
Find out more
U
UBS Portfolio holdings
AUM
$136B
1-Year Est. Return
16.36%
This Fund
S&P 500
This Quarter
Est. Return
-0.23%
1 Year Est. Return
+16.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136B
AUM Growth
+$7.83B
(+6.1%)
Cap. Flow
+$9.38B
Cap. Flow
% of AUM
6.92%
Top 10 Holdings %
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,063
Increased
4,755
Reduced
3,911
Closed
1,116
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$387M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$346M |
| 3 |
Crown Castle
CCI
|
+$229M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$218M |
| 5 |
Toronto Dominion Bank
TD
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
APA Corp
APA
|
+$473M |
| 3 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$453M |
| 4 |
Herc Holdings
HRI
|
+$322M |
| 5 |
PETM
PETSMART INC
PETM
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 8.49% |
| 2 | Technology | 6.67% |
| 3 | Healthcare | 6.67% |
| 4 | Financials | 6.58% |
| 5 | Industrials | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VASC
4726
DELISTED
Vascular Solutions Inc
VASC
| $310K | ﹤0.01% |
12,542
+741
| +6% | +$17.6K |
|
|
CIM
4727
CALL
Chimera Investment
CIM
$1.04B
| $309K | ﹤0.01% |
6,767
| – | – |
|
4728
Fidelity MSCI Utilities Index ETF
FUTY
$2.31B
| $309K | ﹤0.01% |
11,353
+552
| +5% | +$15.2K |
|
|
WWAV
4729
PUT
DELISTED
The WhiteWave Foods Company
WWAV
| $309K | ﹤0.01% |
8,500
| – | – |
|
4730
CALL
AGNC Investment
AGNC
$12.4B
| $308K | ﹤0.01% |
14,500
-65,900
| -82% | -$1.52M |
|
4731
Churchill Downs
CHDN
$5.88B
| $307K | ﹤0.01% |
18,918
-20,796
| -52% | -$320K |
|
4732
Ethan Allen Interiors
ETD
$570M
| $307K | ﹤0.01% |
13,452
-2,015
| -13% | -$48.8K |
|
4733
Nektar Therapeutics
NKTR
$2.39B
| $307K | ﹤0.01% |
1,698
-131
| -7% | -$25.1K |
|
|
NOAH
4734
CALL
Noah Holdings
NOAH
$580M
| $307K | ﹤0.01% |
22,900
+21,600
| +1,662% | +$327K |
|
4735
Vanguard Russell 2000 Growth ETF
VTWG
$1.47B
| $307K | ﹤0.01% |
3,243
+69
| +2% | +$6.73K |
|
|
HVPW
4736
DELISTED
U.S. Equity High Volatility Put Write Index Fund
HVPW
| $306K | ﹤0.01% |
+12,632
| New | +$308K |
|
4737
Calix
CALX
$2.26B
| $305K | ﹤0.01% |
31,842
+12,916
| +68% | +$120K |
|
4738
Evolution Petroleum
EPM
$132M
| $305K | ﹤0.01% |
33,255
-31,195
| -48% | -$322K |
|
|
OXLC
4739
Oxford Lane Capital
OXLC
$894M
| $305K | ﹤0.01% |
3,984
+3,439
| +631% | +$284K |
|
4740
PUT
Sony
SONY
$137B
| $305K | ﹤0.01% |
84,500
-3,000
| -3% | -$10.8K |
|
4741
WesBanco
WSBC
$3.97B
| $305K | ﹤0.01% |
9,956
+7,240
| +267% | +$221K |
|
4742
CALL
NOV
NOV
$6.93B
| $304K | ﹤0.01% |
4,000
-500
| -11% | -$41.3K |
|
4743
PUT
Teck Resources
TECK
$29.6B
| $304K | ﹤0.01% |
16,100
-9,600
| -37% | -$218K |
|
4744
Winnebago Industries
WGO
$856M
| $304K | ﹤0.01% |
13,975
-821
| -6% | -$20.1K |
|
4745
Century Aluminum
CENX
$4.43B
| $303K | ﹤0.01% |
11,650
-28,532
| -71% | -$628K |
|
4746
CALL
Rockwell Medical
RMTI
$28.4M
| $303K | ﹤0.01% |
302
+60
| +25% | +$67.8K |
|
|
BNNY
4747
PUT
DELISTED
ANNIES INC COMMON STOCK (DE)
BNNY
| $303K | ﹤0.01% |
6,600
+2,700
| +69% | +$94.6K |
|
4748
CALL
Bank of Montreal
BMO
$126B
| $302K | ﹤0.01% |
4,100
+1,200
| +41% | +$90.3K |
|
4749
Camden National
CAC
$978M
| $301K | ﹤0.01% |
12,899
+3,380
| +36% | +$81.8K |
|
4750
CALL
Novartis
NVS
$297B
| $301K | ﹤0.01% |
3,571
-14,843
| -81% | -$1.2M |
|
Similar funds
MCM
STC
1IC
QBFM
BCMU
MWR
MGC
BP
UBS's Q3 2014 Portfolio in Review
As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS deployed $9.38B of net new capital in Q3 2014, opening 1,063 new positions and adding to 4,755 existing holdings. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M.
By sector, the portfolio is most concentrated in Energy at 8.5% of assets, down from 8.8% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B trimmed.
- UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
- UBS added most to Amgen in Q3 2014, an estimated $387M increase.
- UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
- UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
- UBS opened 1,063 new positions and closed 1,116 in Q3 2014.
- UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.